Advertisement
Browse Subject Areas
?

Click through the PLOS taxonomy to find articles in your field.

For more information about PLOS Subject Areas, click here.

  • Loading metrics

Open Access

Correction

Correction: Correction: Inactive matrix gla protein plasma levels are associated with peripheral neuropathy in Type 2 diabetes

  • The PLOS ONE Staff

The fifth author’s name is spelled incorrectly in the byline of the correction published on May 5, 2020. The publisher apologizes for the error. The correct name is: Cees Vermeer. The correct citation is: Jeannin A-C, Salem J-E, Massy Z, Aubert CE, Vermeer C, Amouyal C, et al. (2020) Correction: Inactive matrix gla protein plasma levels are associated with peripheral neuropathy in Type 2 diabetes. PLoS ONE 15(5): e0232996. https://doi.org/10.1371/journal.pone.0232996.

References

  1. 1. Jeannin A-C, Salem J-E, Massy Z, Aubert CE, Vemeer C, Amouyal C, et al. (2020) Inactive matrix gla protein plasma levels are associated with peripheral neuropathy in Type 2 diabetes. PLoS ONE 15(2): e0229145. https://doi.org/10.1371/journal.pone.0229145 pmid:32092076
  2. 2. Jeannin A-C, Salem J-E, Massy Z, Aubert CE, Vemeer C, Amouyal C, et al. (2020) Correction: Inactive matrix gla protein plasma levels are associated with peripheral neuropathy in Type 2 diabetes. PLoS ONE 15(5): e0232996. https://doi.org/10.1371/journal.pone.0232996 pmid:32369535

Citation: The PLOS ONE Staff (2021) Correction: Correction: Inactive matrix gla protein plasma levels are associated with peripheral neuropathy in Type 2 diabetes. PLoS ONE 16(3): e0248441. https://doi.org/10.1371/journal.pone.0248441

Published: March 4, 2021

Copyright: © 2021 The PLOS ONE Staff. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.